Target Price | $39.78 |
Price | $12.49 |
Potential |
218.50%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Greenwich LifeSciences Inc 2026 .
The average Greenwich LifeSciences Inc target price is $39.78.
This is
218.50%
register free of charge
$40.95
227.86%
register free of charge
$39.39
215.37%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend Greenwich LifeSciences Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Greenwich LifeSciences Inc stock has an average upside potential 2026 of
218.50%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.21 | -0.96 |
75.36% | 20.66% | |
P/E | negative |
3 Analysts have issued a Greenwich LifeSciences Inc forecast for earnings per share. The average Greenwich LifeSciences Inc EPS is
This results in the following potential growth metrics and future valuations:
2024 | $-1.21 | 75.36% |
---|---|---|
2025 |
$-0.96
20.66%
Unlock
|
Current | -9.91 | 41.34% |
---|---|---|
2025 |
-13.03
31.45%
Unlock
|
Greenwich LifeSciences Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 23 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 21 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 11 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 23 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.